Cogstate Limited Share Price
Stocks
CGS
AU000000CGS8
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
07:10:02 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.740 AUD | -0.36% |
|
+5.38% | +21.24% |
| Market Cap | 465M 329M 285M 267M 244M 458M 0 0 0 0 0 1.21B 0 | P/E 2026 * |
27.9x | P/E 2027 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 408M 289M 250M 235M 214M 402M 0 0 0 0 0 1.06B 0 | EV / Sales 2026 * |
4.7x | EV / Sales 2027 * | 3.84x |
| Free-Float |
54.18% | Yield 2026 * |
1.19% | Yield 2027 * | 1.49% |
Last Transcript: Cogstate Limited
| 1 day | -0.36% | ||
| 1 week | +5.38% | ||
| Current month | +9.60% | ||
| 1 month | -5.52% | ||
| 3 months | +10.93% | ||
| 6 months | +29.25% | ||
| Current year | +21.24% |
| 1 week | 2.56 |  | 2.8 |
| 1 month | 2.42 | | 2.88 |
| Current year | 2.01 | | 3.01 |
| 1 year | 1.57 | | 3.01 |
| 3 years | 0.8 | | 3.01 |
| 5 years | 0.8 | | 3.01 |
| 10 years | 0.16 | | 3.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Maruff
CTO | Chief Tech/Sci/R&D Officer | - | 16/12/1999 |
Bradley O'Connor
CEO | Chief Executive Officer | - | 30/11/2005 |
Darren Watson
DFI | Director of Finance/CFO | - | 31/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Bradley O'Connor
BRD | Director/Board Member | - | 28/02/2011 |
Martyn Myer
CHM | Chairman | 67 | 02/11/2009 |
Richard Mohs
BRD | Director/Board Member | - | 19/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/12/25 | Buy | Director | 10,183 | 0.0059% | ||
| 02/11/25 | Free | Chief Executive Officer | 591,822 | 0.3448% | ||
| 19/10/25 | Fiscal year | Chief Executive Officer | 399,500 | 0.2324% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | +5.38% | +53.93% | +94.33% | 331M | |
| +1.17% | +1.09% | +4.03% | +15.90% | 48.72B | |
| -0.75% | +3.28% | +466.40% | +581.00% | 43.99B | |
| -0.53% | +8.36% | +16.21% | +75.07% | 40.82B | |
| -0.48% | +3.31% | +26.23% | +9.09% | 39.79B | |
| 0.00% | +6.15% | +23.03% | +48.00% | 32.7B | |
| -1.71% | +0.49% | +25.62% | +121.33% | 16.66B | |
| -2.85% | -0.53% | - | - | 16.84B | |
| +0.72% | +0.31% | +4.94% | +21.57% | 13.95B | |
| +0.59% | +7.44% | +84.04% | +31.52% | 13.58B | |
| Average | -0.44% | +3.92% | +78.27% | +110.87% | 26.74B | |
| Weighted average by Cap. | -0.28% | +3.66% | +99.10% | +136.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 86.95M 61.52M 53.3M 49.94M 45.55M 85.63M 0 0 0 0 0 226M 0 | 102M 72.35M 62.68M 58.73M 53.57M 101M 0 0 0 0 0 266M 0 |
| Net income | 16.9M 11.96M 10.36M 9.71M 8.85M 16.64M 0 0 0 0 0 43.92M 0 | 22.92M 16.22M 14.05M 13.17M 12.01M 22.58M 0 0 0 0 0 59.57M 0 |
| Net Debt | -57.17M -40.45M -35.05M -32.84M -29.95M -56.31M -0 -0 -0 -0 -0 -149M -0 | -72.31M -51.16M -44.33M -41.53M -37.88M -71.22M -0 -0 -0 -0 -0 -188M -0 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/08/26 | A$2.740 | -0.36% | 849,793 |
| 12/08/26 | A$2.750 | +1.85% | 1,003,455 |
| 11/08/26 | A$2.700 | +1.12% | 237,911 |
| 10/08/26 | A$2.670 | +3.09% | 64,109 |
| 07/08/26 | A$2.590 | -1.52% | 41,806 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CGS Stock
Select your edition
All financial news and data tailored to specific country editions
